Видео ютуба по тегу Maziar Mike Doustdar

Meet our new CEO, Mike Doustdar
Meet our new CEO, Mike Doustdar
Watch CNBC's full interview with Novo Nordisk CEO Mike Doustdar
Watch CNBC's full interview with Novo Nordisk CEO Mike Doustdar
Mike Doustdar’s Bold Move: Layoffs, Cost-Cuts & Return-To-Office at Novo Nordisk. September 12, 2025
Mike Doustdar’s Bold Move: Layoffs, Cost-Cuts & Return-To-Office at Novo Nordisk. September 12, 2025
Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs
Novo Nordisk CEO Mike Doustdar on $10B Metsera bid, expanding use of obesity drugs
Mike Doustdar Talks Strong Demand for Weight Loss Pills | Bloomberg Talks
Mike Doustdar Talks Strong Demand for Weight Loss Pills | Bloomberg Talks
Novo CEO Sees 'Positive Growth on the Other Side of the Business'
Novo CEO Sees 'Positive Growth on the Other Side of the Business'
Novo Nordisk CEO explains how Trump deal on weight loss drug prices came together
Novo Nordisk CEO explains how Trump deal on weight loss drug prices came together
Генеральный директор Novo Nordisk: Мы уверены, что закроем сделку с Metsera
Генеральный директор Novo Nordisk: Мы уверены, что закроем сделку с Metsera
Novo Nordisk CEO Mike Doustdar Talks Drug Sales | Bloomberg Talks
Novo Nordisk CEO Mike Doustdar Talks Drug Sales | Bloomberg Talks
Novo Nordisk CEO addresses U.S. headwinds after guidance shock
Novo Nordisk CEO addresses U.S. headwinds after guidance shock
Novo Nordisk CEO: Wegovy not only reduces your weight, but it also shows cardiovascular benefits
Novo Nordisk CEO: Wegovy not only reduces your weight, but it also shows cardiovascular benefits
Novo Nordisk plunges as it cuts forecasts and names new CEO | REUTERS
Novo Nordisk plunges as it cuts forecasts and names new CEO | REUTERS
Novo Nordisk President and CEO Talks Wegovy Pill | Bloomberg Talks
Novo Nordisk President and CEO Talks Wegovy Pill | Bloomberg Talks
Novo Nordisk CEO: People have been waiting for a GLP-1 pill
Novo Nordisk CEO: People have been waiting for a GLP-1 pill
BREAKING: Novo Nordisk Names New CEO Amid Wegovy Struggles & Falling Market Share | AF1G
BREAKING: Novo Nordisk Names New CEO Amid Wegovy Struggles & Falling Market Share | AF1G
Novo Nordisk CEO Sees Weight-Loss Market Expanding as Wegovy Pill Goes on Sale
Novo Nordisk CEO Sees Weight-Loss Market Expanding as Wegovy Pill Goes on Sale
Novo CEO Says Volumes to Compensate for Price Decreases
Novo CEO Says Volumes to Compensate for Price Decreases
Novo Nordisk needs something new, outside of weigh-loss drugs, says BMO's Seigerman
Novo Nordisk needs something new, outside of weigh-loss drugs, says BMO's Seigerman
СРОЧНО: Крупный шаг Трампа в сфере здравоохранения — встреча с руководителями фармацевтических ко...
СРОЧНО: Крупный шаг Трампа в сфере здравоохранения — встреча с руководителями фармацевтических ко...
#RZECZOBIZNESIE: Doustdar - Badania kliniczne to rdzeń rozwoju medycyny
#RZECZOBIZNESIE: Doustdar - Badania kliniczne to rdzeń rozwoju medycyny